about
Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and woundsInherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 casesTumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic properties.Pain care for patients with epidermolysis bullosa: best care practice guidelines.Adhesion or plasmin regulates tyrosine phosphorylation of a novel membrane glycoprotein p80/gp140/CUB domain-containing protein 1 in epithelia.Low-level laser therapy for the treatment of epidermolysis bullosa: a case report.Rare case of dysphagia, skin blistering, missing nails in a young boy.Photodynamic therapy for Basal cell carcinoma in recessive dystrophic epidermolysis bullosaWhole-transcriptome gene expression profiling in an epidermolysis bullosa simplex Dowling-Meara model keratinocyte cell line uncovered novel, potential therapeutic targets and affected pathways.Increased risk of squamous cell carcinoma in junctional epidermolysis bullosa.Skin cancer arising in scars: a systematic review.Modelling cancer in human skin tissue.A Cross Sectional, Observational Survey to Assess Levels and Predictors of Psychological Wellbeing in Adults with Epidermolysis BullosaNetwork epidermolysis bullosa: molecular pathomechanisms and novel therapeutic approaches.A Male Patient with Humoral Hypercalcemia of Malignancy (HHM) with Leukocytosis Caused by Cutaneous Squamous Cell Carcinoma Resulting from Recessive Dystrophic Epidermolysis Bullosa.Epidermolysis bullosa. Part 1: causes, presentation and complications.Significance of sentinel node biopsy in the management of squamous cell carcinoma arising from recessive dystrophic epidermolysis bullosa.Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa.Concise review: Transplantation of human hematopoietic cells for extracellular matrix protein deficiency in epidermolysis bullosa.Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines.Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas.Aggressive squamous cell carcinoma in Kindler syndrome.Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma.Altered expression of L-arginine metabolism pathway genes in chronic wounds in recessive dystrophic epidermolysis bullosa.Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-β signalling in modifying disease severity.The psychosocial impact of chronic wounds on patients with severe epidermolysis bullosa.Surgical management of epidermolysis bullosa: Proceedings of the IInd International Symposium on Epidermolysis Bullosa, Santiago, Chile, 2005.Dystrophic epidermolysis bullosa: oral findings and problems.Squamous cell carcinoma in epidermolysis bullosa.Transcriptional Signature of Epidermal Keratinocytes Subjected toin VitroScratch Wounding Reveals Selective Roles for ERK1/2, p38, and Phosphatidylinositol 3-Kinase Signaling PathwaysExpression and glycosylation of MUC1 in epidermolysis bullosa-associated and sporadic cutaneous squamous cell carcinomas
P2860
Q21146433-3AEF2B82-2FEF-4C1A-A16B-21618E0C14F7Q26740232-ECCCC591-CAAA-4548-AFCD-CB53B9C38B7DQ30543779-196B9A4B-7D5A-4EF0-B2D7-DA40EE970164Q30590549-3C8D503E-1A97-4DC3-8AF4-D37E0CA7175EQ31037374-2B72939D-6531-42C9-A17C-909124AB7F82Q33632513-0C6DF774-F3FC-4A2E-AA18-2013A277FDF5Q35075576-1ACBFA77-92C8-413F-873D-80429B386EDEQ35684352-CB8CC434-7C57-48EC-9205-273812775B50Q35868473-FD39E814-CD1A-425D-8266-B3818A1EEC33Q35868532-99D1B63B-3752-47FA-A321-B26A99591EE4Q36249351-374ABB76-10BE-4F12-B6DB-C7E68E4D7A16Q36422870-73BCF63B-6CD2-4228-A3FE-FB2C50D7237EQ36622805-8AD8971E-EEBD-4CAB-91C7-892523AEBDDAQ36765837-D7A4F634-F8D3-4A99-B40C-265780163158Q36943182-0FC81808-11AA-462F-A9BE-AC2F9639023EQ37139139-C3B2F2EF-2B7B-4D74-89D6-23D8AEDA0011Q37199841-5174E43F-B460-44CB-A6A4-EEE3F650441FQ37712686-F922131D-733D-41F9-83F3-10CCBBBB65DFQ37873887-E9FDCCFA-1165-4246-9784-70EB153219CBQ38150897-A63101D1-0240-4490-BCA0-5BAA7C2C30A8Q38572591-B528FFEE-6D9D-489E-A5AC-6F39894048E7Q40011557-EAA33E98-1364-43D4-8D97-7A8835CF7188Q42503794-24CAEFDF-AC00-4909-B78A-F442FFD1F417Q44267573-D254C8D2-A596-4E56-9ABF-BF8042043613Q45154481-B415B8A8-A366-4EFE-A87A-A3BF2BE91F7DQ46149384-7D667057-61B2-417A-8B0D-93C20509DE91Q46197879-11DBDBD9-D027-4C0E-B2AA-FB7C6ED59256Q48580763-3BC21EA4-85A9-4C77-BAFA-E80DBA99455DQ48690987-651CCDF1-9294-4665-BADC-1C567D729B7FQ50970754-8F777A91-68AD-4107-8BD9-DAA4799F32CFQ57372562-8A1A1068-37B7-4A34-8687-64437C69A073Q58039395-989CA280-24C5-44A3-8958-0630DC29DB2B
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Epidermolysis bullosa and cancer.
@ast
Epidermolysis bullosa and cancer.
@en
type
label
Epidermolysis bullosa and cancer.
@ast
Epidermolysis bullosa and cancer.
@en
prefLabel
Epidermolysis bullosa and cancer.
@ast
Epidermolysis bullosa and cancer.
@en
P2860
P1476
Epidermolysis bullosa and cancer.
@en
P2093
Mallipeddi R
P2860
P304
P356
10.1046/J.1365-2230.2002.01130.X
P577
2002-11-01T00:00:00Z